Table 1 The main clinical information of patients with PCA included in our study
From: Characterization and validation of long noncoding RNAs as new candidates in prostate cancer
NO | Gender | Age (Years) | Histological type | Initial total PSA | Gleason score | TNM stage |
|---|---|---|---|---|---|---|
12 | Man | 64 | Adenocarcinoma | 9.39 | 3 + 4 | T2cN0M0 |
34 | Man | 50 | Adenocarcinoma | 15.84 | 4 + 3 | T3bN0M0 |
56 | Man | 62 | Adenocarcinoma | 14 | 4 + 3 | T3bN0M1 |
78 | Man | 54 | Adenocarcinoma | 9.13 | 4 + 3 | T2cN0M0 |
910 | Man | 62 | Adenocarcinoma | 54.66 | 5 + 4 | T3bN1M1 |